GeneTether Therapeutics Inc. Files Preliminary Prospectus for Initial Public Offering

A

admin

Administrator
Jun 17, 2007
66,216
0
36
49
Canada
GeneTether Therapeutics Inc. ("GeneTether" or the "Company"), an innovative genetic medicines company focused on developing gene editing therapies to increase the correction efficiency of targeted genome editing technologies, announces that it has filed a preliminary prospectus (the "Preliminary Prospectus") for a proposed initial public offering (the "Offering") of units of the Company (the "Units"). In addition, the Company obtained a receipt for the Preliminary Prospectus with the securities
 
You must log in or register to reply here.

Similar threads

A
D2L Announces Filing of Final Prospectus and Pricing for $150 Million Initial Public
Replies
0
Views
47
admin
A
A
Apolo IV Completes Initial Public Offering and Listing on the TSXV
Replies
0
Views
67
admin
A
A
Softchoice Corporation Closes Initial Public Offering for Gross Proceeds of C$350 Mil
Replies
0
Views
77
admin
A
A
DoubleVerify Files Registration Statement For An Initial Public Offering
Replies
0
Views
65
admin
A
A
Homology Medicines Announces Pricing of Public Offering of Common Stock
Replies
0
Views
114
admin
A
Back
Top